Skip to main content
Clinical Trials/NCT04901858
NCT04901858
Recruiting
N/A

Pilot Study Into the Structural Local Molecular Environment Following an ACL Injury

Cambridge University Hospitals NHS Foundation Trust1 site in 1 country5 target enrollmentNovember 22, 2019
ConditionsACL Injury

Overview

Phase
N/A
Intervention
Not specified
Conditions
ACL Injury
Sponsor
Cambridge University Hospitals NHS Foundation Trust
Enrollment
5
Locations
1
Primary Endpoint
Pattern of injury on High Definition MRI measured by comparison with 3t MRI images
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

The aim of this pilot study is to understand the biological changes that occur within the knee joint following injury to the anterior cruciate ligament (ACL). This will be achieved through aspiration and analysis of the haemarthrosis which fills the knee following injury. The study will look at inflammatory and healing responses using DNA, RNA and protein analysis.

This, combined with high resolution imaging of the knee and surrounding soft tissue structures, may enable a more patient specific approach to treatment of ACL injury.

Registry
clinicaltrials.gov
Start Date
November 22, 2019
End Date
November 2024
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mr Stephen McDonnell

Principal Investigator

Cambridge University Hospitals NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of ACL injury confirmed by MRI
  • All participants must have the capacity to provide informed consent to participate
  • Participants must be able to comply with required study visit

Exclusion Criteria

  • Participants outside of the specified age range
  • Participants who do not have the mental capacity to make informed decisions
  • Participants who have meniscal pathology or other injuries requiring urgent surgery

Outcomes

Primary Outcomes

Pattern of injury on High Definition MRI measured by comparison with 3t MRI images

Time Frame: Last visit, usually 28 days

Outcome will illustrate any additional benefit of high definition MRI

Secondary Outcomes

  • Identification of acute inflammatory mediators measured by NanoString molecular analysis(Last visit, usually 28 days)

Study Sites (1)

Loading locations...

Similar Trials